Given this company has been compliant for some time now and has made no effort to remove itself from pink sheet status I can only assume an eroded stock value plays into its plans at least for the time being. Its making me wonder if anyone should continue to hold or not. I'm sure if they have any plans at all for the big board they don't want to drop below a dollar but they really haven't tried to make a big splash off the current value either.
Maybe a big board move if this company can meet the eligibility requirements. Would like to see they turn their testimonials, press releases and clinical trial reports into investor relations efforts. Getting off the pinks is just one step; they've got to back it up.